Skip to main content
AMWL
NYSE Trade & Services

Amwell 10-Q Details Q3 Loss of $11.4M, $180.8M Cash and Positive Operating Cash Flow Trend

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$13
Mkt Cap
$216.692M
52W Low
$3.71
52W High
$15.16
52W Position info
250% above low
Off High info
14% below high
Rel. Volume info
1.2× avg
Market data snapshot near publication time

AMWL has more than doubled off its 52-week low of $3.71.

Summary

Amwell's Q3 10-Q shows revenue of $49.0 million, a net loss of $11.4 million, and $180.8 million of cash with no debt; nine-month operating cash burn narrowed to $1.9 million from $48.6 million.


Key Events · Earnings and Guidance · AMWL

  • Q3 Revenue Falls 13% to $49.0M

    Revenue was $48,991K versus $56,286K a year earlier, with subscription revenue down $7.0M on timing with strategic customers and visits down to 760,000 from 1,090,000.

  • Net Loss Widens to $11.4M

    Net loss attributable to American Well was $11,361K, or $0.67 per share, versus $32,378K a year earlier; the sequential comparison is worse than Q2's $9.6M loss.

  • Cash Burn Narrows Sharply

    Nine-month operating cash use was $1,934K versus $48,598K in 2025, leaving $180,786K of cash and no debt, consistent with the Q4 positive operating cash flow target.

  • Cost Cuts Drive the Improvement

    Headcount fell 14% in cost of revenue, 19% in R&D, 39% in sales and marketing and 16% in G&A period over period, plus a $3,424K right-of-use asset impairment from abandoning headquarters.


Analysis · AMWL · Trade & Services

Cash is the headline here: $180.8 million on hand with no debt, and operating cash burn of just $1.9 million for the first nine months versus $48.6 million a year earlier, which supports management's target of positive operating cash flow in Q4. The 10-Q fills in the numbers behind the same-day earnings release, showing Q3 revenue of $49.0 million fell 13% year over year and the net loss attributable to Amwell widened to $11.4 million from $9.6 million in Q2. The offset is that the top line keeps shrinking — subscription revenue dropped $7.0 million on customer timing and visits fell to 760,000 from 1.09 million — so the improving cash position rests on cost cuts (headcount down 14% to 39% across functions) rather than growth.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, AMWL was trading at $13.00 on NYSE in the Trade & Services sector, with a market capitalization of approximately $216.7M. The 52-week trading range was $3.71 to $15.16. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

AMWL - Latest Insights

AMWL
Nov 03, 2026, 4:12 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $12.40
Real-time Price: $10.69 info
Change: -$1.71 (-14%) info
Market Cap: $184.085M info
AMWL
Nov 03, 2026, 4:06 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $12.40
Real-time Price: $10.69 info
Change: -$1.71 (-14%) info
Market Cap: $184.085M info
AMWL
Sep 08, 2026, 8:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $13.22
Real-time Price: $10.69 info
Change: -$2.53 (-19%) info
Market Cap: $184.085M info
AMWL
Aug 10, 2026, 7:37 AM EDT
Source: Wiseek News
Importance Score:
7
Price at Filing: $13.04
Real-time Price: $10.69 info
Change: -$2.35 (-18%) info
Market Cap: $184.085M info
AMWL
Aug 04, 2026, 4:51 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $11.75
Real-time Price: $10.69 info
Change: -$1.06 (-9%) info
Market Cap: $184.085M info